Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MDB vs GSK✓SelectedUSD · GSKMDB vs GSK performance historyLatest closeAs of-3.16%11/19
Stock and ETF performance explorer

MDB vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+826.1%
GSK return
+78.1%
Excess return
+748.1%
Maximum drawdown
-76.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.2%-1.6%-1.6%-2.7%
7D-12.6%-4.7%-7.9%-11.2%
30D-18.9%-4.7%-14.2%-17.8%
3M-32.6%-8.8%-23.8%-30.7%
6M-11.3%-4.6%-6.6%-10.8%
YTD-29.2%+1.0%-30.2%-31.2%
1Y-11.9%+6.9%-18.8%-16.3%
3Y-24.3%+52.5%-76.9%-40.7%
5Y-47.9%+40.3%-88.2%-58.1%
All+826.1%+78.1%+748.1%+555.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling